A Novel Mutation Affecting the Interdomain Link Region of the Growth Hormone Receptor in a Vietnamese Girl, and Response to Long-Term Treatment with Recombinant Human Insulin-Like Growth Factor-I and Luteinizing Hormone-Releasing Hormone Analogue1

Luteinizing Hormone Releasing Hormone ◽

Factor I ◽

Long Term Treatment

A Novel Mutation Affecting the Interdomain Link Region of the Growth Hormone Receptor in a Vietnamese Girl, and Response to Long-Term Treatment with Recombinant Human Insulin-Like Growth Factor-I and Luteinizing Hormone-Releasing Hormone Analogue

The Journal of Clinical Endocrinology & Metabolism ◽

10.1210/jc.83.7.2554 ◽

1998 ◽

Vol 83 (7) ◽

pp. 2554-2561 ◽

Cited By ~ 11

Author(s):

J. L. Walker

Keyword(s):

Growth Hormone ◽

Growth Hormone Receptor ◽

Novel Mutation ◽

Term Treatment ◽

Hormone Analogue ◽

Luteinizing Hormone Releasing Hormone ◽

Factor I ◽

Long Term Treatment

Body changes in adolescent patients with growth hormone receptor deficiency receiving recombinant human insulin-like growth factor I and luteinizing hormone-releasing hormone analogue: preliminary results

Acta Paediatrica ◽

10.1111/j.1651-2227.1994.tb13306.x ◽

1994 ◽

Vol 83 (s399) ◽

pp. 133-136 ◽

Cited By ~ 13

Author(s):

V Martinez ◽

O Vasconez ◽

AL Martinez ◽

Z Moreno ◽

N Davila ◽

...

Keyword(s):

Growth Hormone ◽

Growth Factor ◽

Luteinizing Hormone ◽

Human Insulin ◽

Hormone Receptor ◽

Growth Hormone Receptor ◽

Hormone Analogue ◽

Luteinizing Hormone Releasing Hormone ◽

Factor I

Further Observations on the Effects of Long-Term Treatment with Recombinant Human Insulin-Like Growth Factor 1 in Growth Hormone Insensitivity Syndrome

Hormone Research in Paediatrics ◽

10.1159/000357267 ◽

2014 ◽

Vol 81 (4) ◽

pp. 258-265 ◽

Cited By ~ 1

Author(s):

Mohamed El Kholy ◽

Nermine Hussein Amr ◽

Heba Elsedfy

Keyword(s):

Growth Hormone ◽

Growth Factor ◽

Human Insulin ◽

Term Treatment ◽

Long Term Treatment ◽

Growth Hormone Insensitivity

Relative Deficiency in Circulating Levels of Insulin-Like Growth Factor I (IGF-I) During Long-Term Treatment with a GnRH Agonist

Hormone and Metabolic Research ◽

10.1055/s-2007-979081 ◽

1997 ◽

Vol 29 (09) ◽

pp. 472-474

Author(s):

C. Fiore ◽

M. Dieli ◽

S. Caschetto ◽

A. Cirino ◽

E. Cottini

Keyword(s):

Growth Factor ◽

Gnrh Agonist ◽

Term Treatment ◽

Factor I ◽

Long Term Treatment ◽

Igf I ◽

Relative Deficiency ◽

Circulating Levels

Long‐Term Treatment of Swiss 3T3 Fibroblasts with Dexamethasone Attenuates MAP Kinase Activation Induced by Insulin‐Like Growth Factor‐I (IGF‐I)

Cell Biochemistry and Function ◽

10.1002/(sici)1099-0844(199606)14:2<121::aid-cbf656>3.0.co;2-q ◽

1996 ◽

Vol 14 (2) ◽

pp. 121-129 ◽

Cited By ~ 1

Author(s):

ANDERS HANSSON ◽

KARIN HEHENBERGER ◽

MARJA THORÉN

Keyword(s):

Growth Factor ◽

Map Kinase ◽

Term Treatment ◽

Kinase Activation ◽

Factor I ◽

3T3 Fibroblasts ◽

Long Term Treatment ◽

Igf I ◽

Swiss 3T3 Fibroblasts

Recombinant Human Insulin-Like Growth Factor I Has Significant Anabolic Effects in Adults with Growth Hormone Receptor Deficiency: Studies on Protein, Glucose, and Lipid Metabolism

The Journal of Clinical Endocrinology & Metabolism ◽

10.1210/jc.85.9.3036 ◽

2000 ◽

Vol 85 (9) ◽

pp. 3036-3042 ◽

Cited By ~ 19

Author(s):

N. Mauras

Keyword(s):

Growth Hormone ◽

Lipid Metabolism ◽

Growth Factor ◽

Human Insulin ◽

Hormone Receptor ◽

Growth Hormone Receptor ◽

Factor I ◽

Glucose And Lipid Metabolism

Insulin-like growth factor-I decreases serum lipoprotein(a) during long-term treatment of patients with Laron syndrome

Metabolism ◽

10.1016/s0026-0495(96)90245-0 ◽

1996 ◽

Vol 45 (10) ◽

pp. 1263-1266 ◽

Cited By ~ 15

Author(s):

Z. Laron ◽

X.L. Wang ◽

B. Klinger ◽

A. Silbergeld ◽

D.E.L. Wilcken

Keyword(s):

Growth Factor ◽

Term Treatment ◽

Serum Lipoprotein ◽

Laron Syndrome ◽

Lipoprotein A ◽

Factor I ◽

Long Term Treatment ◽

Growth Factor I

Long-term treatment of swiss 3T3 fibroblasts with dexamethasone attenuates MAP kinase activation induced by insulin-like growth factor-I (IGF-I)

Cell Biochemistry and Function ◽

10.1002/cbf.656 ◽

1996 ◽

Vol 14 (2) ◽

pp. 121-129

Author(s):

Anders Hansson ◽

Karin Hehenberger ◽

Marja Thorén

Keyword(s):

Growth Factor ◽

Map Kinase ◽

Term Treatment ◽

Kinase Activation ◽

Factor I ◽

3T3 Fibroblasts ◽

Long Term Treatment ◽

Igf I ◽

Swiss 3T3 Fibroblasts

Expression of estrogen receptors (α, β) and insulin-like growth factor-I in breast tissue from surgically postmenopausal cynomolgus macaques after long-term treatment with HRT and tamoxifen

The Breast ◽

10.1054/brst.2002.0422 ◽

2002 ◽

Vol 11 (4) ◽

pp. 295-300 ◽

Cited By ~ 9

Author(s):

E. Isaksson ◽

H. Wang ◽

L. Sahlin ◽

B. von Schoultz ◽

B. Masironi ◽

...

Keyword(s):

Growth Factor ◽

Estrogen Receptors ◽

Breast Tissue ◽

Term Treatment ◽

Factor I ◽

Long Term Treatment ◽

Cynomolgus Macaques ◽

Growth Factor I

Octreotide long term treatment of acromegaly: effect of drug withdrawal on serum growth hormone/insulin-like growth factor-I concentrations and on serum gastrin/24-hour intragastric pH values

The Journal of Clinical Endocrinology & Metabolism ◽

10.1210/jc.77.1.157 ◽

1993 ◽

Vol 77 (1) ◽

pp. 157-162 ◽

Cited By ~ 2

Author(s):

U. Plockinger

Keyword(s):

Growth Hormone ◽

Drug Withdrawal ◽

Serum Gastrin ◽

Term Treatment ◽

Intragastric Ph ◽

Serum Growth Hormone ◽

Factor I ◽

Ph Values ◽

Long Term Treatment